Dr. Raj Amin in the Department of Pharmacal Sciences in the Harrison School of Pharmacy studies the effects of thiazolindiones, (TZDs) upon preventing the development of diabetic cardiomyopathy. Previously Dr. Amin has shown that TZDs prevent many of the manifestations of diabetic cardiomyopathy, including myocardial remodeling. Dr. Amin's long term goal is to develop compounds which will prevent many of the harmful effects of type 2 diabetes upon the heart by improving cardiac energy metabolism. MRI is used to image changes in heart mass and heart function to determine the levels by which our compounds prevent the development of diabetic cardiomyopathy.

Last Updated: Jun 20, 2017